| Dr Matthew Harold Bucher, MD | |
|
1001 Leawood Dr, Frankfort, KY 40601-3375 | |
| (502) 223-0231 | |
| Not Available |
| Full Name | Dr Matthew Harold Bucher |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 19 Years |
| Location | 1001 Leawood Dr, Frankfort, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295939791 | NPI | - | NPPES |
| 7100041910 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 41280 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Nurse On Call | Lexington, KY | Home health agency |
| Hospice Of The Bluegrass, Inc Dba Bluegrass Care N | Lexington, KY | Hospice |
| Frankfort Regional Medical Center | Frankfort, KY | Hospital |
| Baptist Health Lexington | Lexington, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Proactive Therapy, Inc | 0143245415 | 58 |
| Baptist Health Medical Group Inc | 5597867184 | 1912 |
News Archive
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent Office (USPTO) has allowed a patent (Application No. 10/560,336) for the Woppmann et al. patent series, entitled "Double-stranded ribonucleic acid with increased effectiveness in an organism." The newly allowed patent includes 31 claims broadly covering compositions and methods, including pharmaceutical compositions, for small interfering RNAs (siRNAs), the molecules that mediate RNAi.
Parkinson's, Alzheimer's, stroke, migraine, epilepsy, cancer and autoimmune and metabolic disorders – these are examples of diseases that will be explored by the three Nordic networks that have been granted financial support from the joint Nordic venture "Nordic Centre of Excellence Programme in Molecular Medicine".
Significant weaknesses undermine the global community's abilities to prevent, detect early, and respond efficiently to potentially deadly species-crossing microbes, such as the pandemic H1N1 influenza virus sweeping the globe, says a new report from the Institute of Medicine and National Research Council. The report provides a detailed plan for establishing and funding a comprehensive, globally coordinated system to identify novel zoonotic disease threats as early as possible wherever they arise so appropriate measures can be taken to prevent significant numbers of human illnesses and deaths, and livestock losses.
Unhealthy weight gain in pregnancy has been linked with postpartum weight retention but until now its long-term effects had been understudied in low-income and minority populations who are at high risk for obesity.
People should be warned that cancer is linked to obesity and alcohol, rather than urged to eat more fruit and vegetables to protect against the disease.
› Verified 3 days ago
| Entity Name | Capital Family Physicians Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780628974 PECOS PAC ID: 2668454323 Enrollment ID: O20040605000000 |
News Archive
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent Office (USPTO) has allowed a patent (Application No. 10/560,336) for the Woppmann et al. patent series, entitled "Double-stranded ribonucleic acid with increased effectiveness in an organism." The newly allowed patent includes 31 claims broadly covering compositions and methods, including pharmaceutical compositions, for small interfering RNAs (siRNAs), the molecules that mediate RNAi.
Parkinson's, Alzheimer's, stroke, migraine, epilepsy, cancer and autoimmune and metabolic disorders – these are examples of diseases that will be explored by the three Nordic networks that have been granted financial support from the joint Nordic venture "Nordic Centre of Excellence Programme in Molecular Medicine".
Significant weaknesses undermine the global community's abilities to prevent, detect early, and respond efficiently to potentially deadly species-crossing microbes, such as the pandemic H1N1 influenza virus sweeping the globe, says a new report from the Institute of Medicine and National Research Council. The report provides a detailed plan for establishing and funding a comprehensive, globally coordinated system to identify novel zoonotic disease threats as early as possible wherever they arise so appropriate measures can be taken to prevent significant numbers of human illnesses and deaths, and livestock losses.
Unhealthy weight gain in pregnancy has been linked with postpartum weight retention but until now its long-term effects had been understudied in low-income and minority populations who are at high risk for obesity.
People should be warned that cancer is linked to obesity and alcohol, rather than urged to eat more fruit and vegetables to protect against the disease.
› Verified 3 days ago
| Entity Name | Baptist Health Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518360296 PECOS PAC ID: 5597867184 Enrollment ID: O20150206000249 |
News Archive
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent Office (USPTO) has allowed a patent (Application No. 10/560,336) for the Woppmann et al. patent series, entitled "Double-stranded ribonucleic acid with increased effectiveness in an organism." The newly allowed patent includes 31 claims broadly covering compositions and methods, including pharmaceutical compositions, for small interfering RNAs (siRNAs), the molecules that mediate RNAi.
Parkinson's, Alzheimer's, stroke, migraine, epilepsy, cancer and autoimmune and metabolic disorders – these are examples of diseases that will be explored by the three Nordic networks that have been granted financial support from the joint Nordic venture "Nordic Centre of Excellence Programme in Molecular Medicine".
Significant weaknesses undermine the global community's abilities to prevent, detect early, and respond efficiently to potentially deadly species-crossing microbes, such as the pandemic H1N1 influenza virus sweeping the globe, says a new report from the Institute of Medicine and National Research Council. The report provides a detailed plan for establishing and funding a comprehensive, globally coordinated system to identify novel zoonotic disease threats as early as possible wherever they arise so appropriate measures can be taken to prevent significant numbers of human illnesses and deaths, and livestock losses.
Unhealthy weight gain in pregnancy has been linked with postpartum weight retention but until now its long-term effects had been understudied in low-income and minority populations who are at high risk for obesity.
People should be warned that cancer is linked to obesity and alcohol, rather than urged to eat more fruit and vegetables to protect against the disease.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Matthew Harold Bucher, MD Po Box 4168, Frankfort, KY 40604-4168 Ph: (502) 223-5811 | Dr Matthew Harold Bucher, MD 1001 Leawood Dr, Frankfort, KY 40601-3375 Ph: (502) 223-0231 |
News Archive
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent Office (USPTO) has allowed a patent (Application No. 10/560,336) for the Woppmann et al. patent series, entitled "Double-stranded ribonucleic acid with increased effectiveness in an organism." The newly allowed patent includes 31 claims broadly covering compositions and methods, including pharmaceutical compositions, for small interfering RNAs (siRNAs), the molecules that mediate RNAi.
Parkinson's, Alzheimer's, stroke, migraine, epilepsy, cancer and autoimmune and metabolic disorders – these are examples of diseases that will be explored by the three Nordic networks that have been granted financial support from the joint Nordic venture "Nordic Centre of Excellence Programme in Molecular Medicine".
Significant weaknesses undermine the global community's abilities to prevent, detect early, and respond efficiently to potentially deadly species-crossing microbes, such as the pandemic H1N1 influenza virus sweeping the globe, says a new report from the Institute of Medicine and National Research Council. The report provides a detailed plan for establishing and funding a comprehensive, globally coordinated system to identify novel zoonotic disease threats as early as possible wherever they arise so appropriate measures can be taken to prevent significant numbers of human illnesses and deaths, and livestock losses.
Unhealthy weight gain in pregnancy has been linked with postpartum weight retention but until now its long-term effects had been understudied in low-income and minority populations who are at high risk for obesity.
People should be warned that cancer is linked to obesity and alcohol, rather than urged to eat more fruit and vegetables to protect against the disease.
› Verified 3 days ago
Dr. John D. Stewart Ii, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4200 Lawrenceburg Rd, Frankfort, KY 40601 Phone: 502-227-4821 Fax: 502-227-3013 | |
Gregory Fuqua, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1001 Leawood Dr, Frankfort, KY 40601 Phone: 502-223-0231 Fax: 502-227-1871 | |
Steven Crum, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4 Hmb Cir, Frankfort, KY 40601 Phone: 502-695-7725 | |
Anthony Barnes, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4 Hmb Cir, Frankfort, KY 40601 Phone: 502-695-7725 | |
Anne-margaret Elizabeth Brown, APRN Family Medicine Medicare: Medicare Enrolled Practice Location: 300 Blue Spruce Dr, Frankfort, KY 40601 Phone: 502-330-3654 | |
Frank Donald Farley Iii, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 593 E Main St, Frankfort, KY 40601 Phone: 502-223-0308 Fax: 502-227-5764 |